Login or Register to make a submission.

Author Guidelines

AMSUM consider for publication manuscripts written in English and this language is the only suitable for correspondence with Editors. Authors are invited to submit manuscripts written correctly, an English control by a professional service or mother tongue expert is recommended. If abbreviations are used in the text they should be defined in the text at their first use. Manuscripts should be submitted including a title page, abstract, introduction, methods, results, discussion, conclusion, references. 


All manuscripts must be submitted using the online platform of the journal. Article send by email or printed paper will not be considered for the review process. Submitting a manuscript all the authors declare that the work has not been published before and is not under consideration for publication in other journals.

NO submission or publication fees.

Title page

A separate title page includes Full Title, List of Authors with all Affiliations, Name of the corresponding author, full contact (email, Phone number, Address). Any acknowledgements, disclosures, or funding information should also be included on this page.  Insert a statement reporting that the publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out. The publisher and all the editorial board, and reviewers, will not be held legally responsible should there be any claims for compensation.


The blinded manuscript must be submitted without any author names and affiliations in the text. Self-identifying citations and references in the article text should be avoided.


The title should be short and express clearly the topic of the study. The title should not be a question.



AMSUM require a structured abstract (purpose, methods, results and discussion) and should not exceed 300 words. Keywords and the Level of Evidence should be clearly noted separately at the end of the abstract. The type of study should be stated (Meta-analysis, Literature Review, Randomized controlled trial, cohort study, cross-sectional study, Case report, case control study). Level of Evidence should be reported.



The introduction should describe in a concise way the background of the topic of the article, highlighting why the authors found of interest to perform the study. Authors do not have to report general information and are invited to express clearly, in a final statement, hypothesis and aim of the study.



The methodology of the study has to be clearly described, with specific differences related to the particular kind of scientific work. The cohort of patients has to be adequately reported (age, sex distribution, concomitant injuries, surgical procedure) and if different groups take part to the study all have to be described clearly. A previous power analysis is not required but the size of groups has to guarantee an appropriate dimension to permit a correct statistical analysis. In randomized controlled trial the randomization has to be described clearly. The studies have to respect the set of ethical principles regarding human experimentation included in the declaration of Helsinki. The ethical committee approval has to be included in the methods section if available. For prospective randomized trials if inserted in a clinical study the insertion in a clinical study register is recommended. 



Results have to report data directly connected to the aim of the study and to the method section. Data have to be described clearly, with numbers and percentage. All statistical values (f.e. Standard Deviation) have to be written clearly. The use of figures and tables is promoted by the editor, avoid repetition of data in the text.


Discussion should start with a statement reporting the most relevant finding of the study. An up-to-date of literature is recommended but this information should be reported in a critical way, with scientific supported statements. Authors should include in this section the limits of the work and potential new field of research opened by the manuscript.


Conclusions have to be short, concise and only based upon data contained within the manuscript. 

All sources of funding for the research reported should be declared. The role of the funding society/company in the design of the study and collection, analysis, and interpretation of data and in writing the manuscript should be declared.


All figures and tables must be added at the end of the manuscript, after the references list. Figures and table must have specific Arabic numbers, inserted in the text in order of appearance. A description of figures and tables should be inserted just after the reference list, before the figures. 

As example a figure or table should be added in this way:

The figure of the patient with this pathology [Fig 1].

The table reports clinical outcomes [Tab 1].

Identify any previously published material by giving the original source in the form of a reference at the end of the table caption. If the material is subject to copyright, a permission to the owner of the rights have to be obtained by authors.


Reference citations in the text should be identified by numbers in square brackets. Some examples:

1. The hand of the patient was infected [3].

2. This paper is of interest [5].

3. Many studies support this theory [1-3, 7].


Reference list 

The list of references should only include works that are cited in the text and that have been published or accepted for publication. Personal communications and unpublished works should only be mentioned in the text without references in the final list. Do not include comments or note in the references list. The entries in the list should be numbered consecutively as they appear in the text.


Journal article

Randelli P, Randelli F, Compagnoni R, Cabitza P, Ragone V, Pulici L, Banfi G. (2015) Revision reverse shoulder arthroplasty in failed shoulder arthroplasties for rotator cuff deficiency. Joints.  Jun 8;3(1):31-7.

Ideally, the names of all authors should be provided, but the usage of “et al” in long author lists will also be accepted:

Ahmad SS, Meyer JC, Krismer AM, Ahmad SS, Evangelopoulos DS, Hoppe S, et al. (2017) Outcome measures in clinical ACL studies: an analysis of highly cited level I trials. Knee Surg Sports Traumatol Arthrosc. 25(5):1517-152

ARTICLE BY DOI (before issue publication and with page numbers)
Evangelopoulos DS, Kohl S, Schwienbacher S, Gantenbein B, Exadaktylos A, Ahmad SS (2015) Collagen application reduces complication rates of mid-substance ACL tears treated 312 with dynamic intraligamentary stabilization. Knee Surg Sports Traumatol Arthrosc. DOI: 10.1007/s00167-015-3838-7


Compagnoni R., Cabitza F., Randelli P.S. (2018) Sliding Knots. In: Akgun U., Karahan M., Randelli P., Espregueira-Mendes J. (eds) Knots in Orthopedic Surgery. Springer, Berlin, Heidelberg



Cartwright J (2007) Big stars have weather too. IOP Publishing PhysicsWeb. http://physicsweb.org/articles/news/11/6/16/1. Accessed 26 June 2008


Always use the standard abbreviation of a journal’s name according to the ISSN List of Title Word Abbreviations.

For authors using EndNote, provides an output style that supports the formatting of in-text citations and reference list in order of appearance in the text.


Informed consent: 

All manuscripts should include the statement “Informed consent was obtained from all individual participants included in the study.” 

If identifying information about participants is available in the article, the following statement should be included:

“Additional informed consent was obtained from all individual participants for whom identifying information is included in this article.”

Data Availability

Authors must follow standards and practice for data deposition in publicly available resources including those created for gene sequences, microarray expression, structural studies, and similar kinds of data. Failure to comply with community standards may result in rejection.

For more information about PLOS ONE requirements for data sharing and deposition in public databases, see our data availability policy.


Privacy Statement

All submitted material will be be treated as strictly confidential until published.

The peer review process is confidential to all parties. Correspondence as part of the review process is also to be treated confidentially by all parties, including authors.

Authors may provide basic details about the nature of the research presented in manuscripts currently under review.

Editors and reviewers are required to treat all submitted manuscripts in strict confidence and should not share information about submissions with any other parties unless previously agreed with the editor. The involvement of a third party in the review must be declared at the time of the submission of the review.

We expect that editors and reviewers will not make use of any material or take advantage of any information they gain through the peer review process.